These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36371726)

  • 1. Factors affecting healing and progression of conservatively treated incomplete atypical femoral fractures: retrospective observational study.
    Png MA; Koh JSB; Mohan PC; Howe CY; Howe TS
    J Bone Miner Metab; 2023 Jan; 41(1):61-73. PubMed ID: 36371726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
    J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy.
    Chiang CY; Zebaze RM; Ghasem-Zadeh A; Iuliano-Burns S; Hardidge A; Seeman E
    Bone; 2013 Jan; 52(1):360-5. PubMed ID: 23072919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
    J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete atypical femoral fractures after bisphosphonate use in postmenopausal women.
    Canbek U; Akgun U; Soylemez D; Canbek TD; Aydogan NH
    J Orthop Surg (Hong Kong); 2019; 27(3):2309499019875262. PubMed ID: 31547771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S
    Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
    J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management.
    Koh A; Guerado E; Giannoudis PV
    Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
    Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
    Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
    N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?
    Tarazona-Santabalbina FJ; Aguilella-Fernández L
    Aging Clin Exp Res; 2013 Oct; 25(5):605-9. PubMed ID: 24026625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
    Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
    Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.
    Kang JS; Won YY; Kim JO; Min BW; Lee KH; Park KK; Song JH; Kim YT; Kim GH
    Int Orthop; 2014 Jun; 38(6):1247-53. PubMed ID: 24464018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
    Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and their influence on fracture healing: a systematic review.
    Molvik H; Khan W
    Osteoporos Int; 2015 Apr; 26(4):1251-60. PubMed ID: 25572046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation.
    Shin WC; Moon NH; Jang JH; Seo HU; Suh KT
    Bone; 2019 Nov; 128():115033. PubMed ID: 31398503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.